<DOC>
	<DOCNO>NCT00083967</DOCNO>
	<brief_summary>The purpose study test denufosol remove fluid build-up eye retina re-attached without invasive surgery .</brief_summary>
	<brief_title>Study Denufosol ( INS37217 ) Subjects With Rhegmatogenous Retinal Detachment</brief_title>
	<detailed_description>The purpose trial determine administration denufosol well-tolerated efficacious placebo stimulate subretinal fluid reabsorption retinal reattachment without surgical intervention subject present rhegmatogenous retinal detachment .</detailed_description>
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<criteria>rhegmatogenous retinal detachment one eye able receive intravitreal injection study drug able wait 24 ( +/ 6 ) hour detachment surgically treat retinal break repair per judgement investigator 3 separate identifiable retinal break cluster together confine within area 2 clock hour extent retinal detachment must large enough immediately repair laser photocoagulation cryotherapy pinhole acuity ( use ETDRS ) maculaon , 20/50 good eye OR maculaoff , 20/50 good nonstudy eye history , prior detachment , read capability study eye nonrhegmatogenous retinal detachment large retinal break ( ) whose total break area great 1 clock hour extent evidence atrophic retinal pigment epithelium , choroid , choroidal detachment intraocular inflammation monocular prior retinal detachment repair congenital condition place great risk rhegmatogenous retinal detachment proliferative vitreoretinopathy great grade B preexist subretinal vitreous hemorrhage , corneal opacity , condition limit view peripheral retina coexist macular pathology retinal condition limit visual acuity currently uncontrollable elevate intraocular pressure , advance glaucoma , history current evidence endophthalmitis affect eye symptom consistent rhegmatogenous retinal detachment visual disturbance great 14 day prior screen maculaon OR history loss read vision affect eye great 6 day prior screen maculaoff retinal detachment evidence demarcation line evidence subretinal fibrosis visible upon fundus examination currently take medication could obscure confound study result include acetazolamide ( Diamox ) dorzolamide periocular , retrobulbar intravitreal injection affect eye , include corticosteroid 3 month prior screen require one</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>rhegmatogenous retinal detachment</keyword>
	<keyword>detach retina</keyword>
	<keyword>retinal tear</keyword>
	<keyword>retinal break</keyword>
</DOC>